Naturally occurring glucagon-like peptide-2 (GLP-2) receptors in human intestinal cell lines

被引:8
|
作者
Sams, A
Hastrup, S
Andersen, M
Thim, L
机构
[1] Novo Nordisk AS, Dept Mol Pharmacol, DK-2760 Malov, Denmark
[2] Novo Nordisk AS, Dept Microbial Cell Technol, DK-2760 Malov, Denmark
[3] Novo Nordisk AS, Dept Prot Engn, DK-2760 Malov, Denmark
关键词
GLP-2; receptor; G alpha protein signalling; intestinal growth; RT-PCR; western blot; cAMP;
D O I
10.1016/j.ejphar.2005.12.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Although clinical trials with GLP-2 receptor agonists are currently ongoing, the mechanisms behind GLP-2-induced intestinal epithelial growth remain to be understood. To approach the GLP-2 mechanism of action this study aimed to identify intestinal cell lines endogenously expressing the GLP-2 receptor. Here we report the first identification of a cell line endogenously expressing functional GLP-2 receptors. The human intestinal epithelial cell line, FHC, expressed GLP-2 receptor encoding mRNA (RT-PCR) and GLP-2 receptor protein (Western blot). In cultured FHC cells, GLP-2 induced concentration dependent cAMP accumulation (pEC50=9.7 +/- 0.04 (mean S.E.M., n=4)). In addition, a naturally occurring human intestinal fibroblast cell line, 18Co, endogenously expressing GLP-2 receptor encoding mRNA (RTPCR) and protein (Western blot) was identified. No receptor functionality (binding or G-protein signalling) could be demonstrated in 18Co cells. The identified gut-relevant cell lines provide tools for future clarification of the mechanisms underlying GLP-2-induced epithelial growth. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:18 / 23
页数:6
相关论文
共 50 条
  • [31] Synthesis and Pharmacological Characterization of Novel Glucagon-like Peptide-2 (GLP-2) Analogues with Low Systemic Clearance
    Wisniewski, Kazimierz
    Sueiras-Diaz, Javier
    Jiang, Guangcheng
    Galyean, Robert
    Lu, Mark
    Thompson, Dorain
    Wang, Yung-Chih
    Croston, Glenn
    Posch, Alexander
    Hargrove, Diane M.
    Wisniewska, Halina
    Laporte, Regent
    Dwyer, John J.
    Qi, Steve
    Srinivasan, Karthik
    Hartwig, Jennifer
    Ferdyan, Nicky
    Mares, Monica
    Kraus, John
    Alagarsamy, Sudarkodi
    Riviere, Pierre J. M.
    Schteingart, Claudio D.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (07) : 3129 - 3139
  • [32] Identification of glucagon-like peptide-2 (GLP-2)-activated signaling pathways in baby hamster kidney fibroblasts expressing the rat GLP-2 receptor
    Yusta, B
    Somwar, R
    Wang, F
    Munroe, D
    Grinstein, S
    Klip, A
    Drucker, DJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (43) : 30459 - 30467
  • [33] Glucagon-like peptide-2
    Estall, Jennifer L.
    Drucker, Daniel J.
    ANNUAL REVIEW OF NUTRITION, 2006, 26 : 391 - 411
  • [34] A novel truncated glucagon-like peptide 2 (GLP-2) as a tool for analyzing GLP-2 receptor agonists
    Yamazaki, Kazuto
    Kagaya, Takaki
    Watanabe, Misako
    Terauchi, Hiroki
    Iida, Daisuke
    Fukumoto, Hironori
    Suzuki, Shuichi
    Arai, Tohru
    Aoki, Mika
    Takase, Kazuma
    Seiki, Takashi
    Tsukahara, Kappei
    Nagakawa, Junichi
    BIOMEDICAL RESEARCH-TOKYO, 2013, 34 (03): : 129 - 136
  • [35] Pharmacokinetics (PK) Profile of FE 203799: A Novel Long Acting Peptide Agonist of Glucagon-Like Peptide-2 (GLP-2)
    Srinivasan, Karthik
    Qi, Steve
    Hargrove, Diane
    Hartwig, Jennifer
    Ferdyan, Nicky
    Alagarsamy, Sudar
    Croston, Glenn
    Laporte, Regent
    Sueiras-Diaz, Javier
    Wisniewski, Kazimierz
    Wisniewska, Halina
    Lu, Mark
    Posch, Alexander
    Schteingart, Claudio
    Riviere, Pierre
    BIOPOLYMERS, 2011, 96 (04) : 489 - 489
  • [36] Accelerated intestinal epithelial restitution: A novel biological action of glucagon-like peptide 2 (GLP-2)
    Fei, MW
    Tavakkolizadeh, A
    Ashley, SW
    Zinner, MJ
    Whang, EE
    GASTROENTEROLOGY, 2001, 120 (05) : A504 - A505
  • [37] In Vivo degradation of glucagon-like peptide 2 (GLP-2) and Gly2-GLP-2
    Hare, KJ
    Hartmann, B
    Deacon, CF
    Holst, JJ
    GASTROENTEROLOGY, 2003, 124 (04) : A273 - A273
  • [38] Glucagon-like peptide 2 (GLP-2): an underestimated signal in metabolic control
    Vendrell, J. J.
    Ejarque, M.
    Beiroa, D.
    Calvo, E.
    Keiran, N.
    Nunez Roa, C.
    Nogueiras, R.
    Fernandez-Veledo, S.
    DIABETOLOGIA, 2018, 61 : S279 - S279
  • [39] Glucagon-like peptide 2 (GLP-2) in bovine colostrum and transition milk
    Inabu, Yudai
    Yamamoto, Hiroshi
    Yamano, Haruki
    Taguchi, Yutaka
    Okada, Shunnosuke
    Etoh, Tetsuji
    Shiotsuka, Yuji
    Fujino, Ryoichi
    Takahashi, Hideyuki
    HELIYON, 2021, 7 (05)
  • [40] Enhancement of intestinal epithelial repair by a human glucagon-like peptide-2 analogue, h[Gly2]-GLP-2, in a murine model of ulcerative colitis.
    Drucker, DJ
    DeForest, L
    Yusta, B
    Brubaker, PL
    GASTROENTEROLOGY, 1998, 114 (04) : A968 - A968